Press release
Bacterial Diagnostics in Aquaculture Market expected to Witness Huge Revenue Growth to 2031
According to the latest research by InsightAce Analytic, the Global Bacterial Diagnostics in Aquaculture Market is valued at US$ 3.76 Bn in 2022, and it is expected to reach US$ 6.46 Bn by 2031, with a CAGR of 6.4% during a forecast period of 2023-2031.
Request for Sample Pages:
https://www.insightaceanalytic.com/request-sample/2056
Bacterial diagnostics in aquaculture is the diagnosis and monitoring of bacterial infections that can influence the health and productivity of aquatic species in aquaculture systems, such as fish and shellfish. Bacterial infections can cause considerable economic losses in the aquaculture business by reducing production, increasing mortality, and incurring additional costs for disease management and treatment. Bacterial diagnostics have become faster and more accurate as molecular diagnostic tools such as PCR and DNA sequencing have advanced. These tools enable rapid pathogen identification and timely response. As aquaculture production grows, so does the demand for reliable bacterial diagnostics to protect the health of aquatic species. The increase in demand for seafood in aquaculture is thought to have considerable growth in the global food production industry, ascribed to increased demand for seafood, particularly in developing countries.
List of Prominent Players in the Bacterial Diagnostics in Aquaculture Market:
• Aquasol Corporation
• Ziva Impex Pvt Ltd.
• Aquatic Diagnostics Ltd
• Mologic
• Biogenuix
• Auro Biotechnologies
• Enasis Indonesia
• Thermo Fisher Scientific
• LexaGene
• Myron L
Market Dynamics:
Drivers-
The globalization of the seafood sector emphasizes the necessity of disease-free products in maintaining access to international markets. Bacterial diagnostics enable the verification of the health state of aquaculture products, hence supporting export and trade opportunities. Furthermore, advances in diagnostic technology, such as molecular procedures like PCR and LAMP, have enhanced the accuracy and efficiency of bacterial diagnostics. These technologies provide rapid and specific disease detection, increasing their implementation in the aquaculture sector.
Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/2056
Challenges:
Aquaculture involves a variety of fish and shellfish species, each of which is susceptible to a variety of bacterial infections. It is a huge problem to develop diagnostics that can reliably identify a large range of bacterial illnesses and infections. Additionally, precise identification of bacterial pathogens is critical for illness management. To minimize false positives or false negatives that could lead to improper treatment decisions, diagnostic tests must be very specific and sensitive.
Regional Trends:
Asia Pacific Bacterial Diagnostics in the Aquaculture Market is expected to record a maximum market share in revenue and it is projected to grow at a high CAGR in the near future. Aquaculture operations in the Asia Pacific region span from small-scale farms to major commercial enterprises. Bacterial diagnostics solutions must address these enterprises' various needs and resources. The different climate zones and environmental circumstances of the Asia Pacific area can impact disease patterns.
Moreover, Aquaculture in North America encompasses a wide range of species, production technologies (ponds, recirculating systems, and offshore operations), and geographic locations. This diversity impacts the dynamics of bacterial detection and necessitates flexible treatments.
Recent Developments:
• In July 2020, NanoPin Technologies, Inc. and Thermo Fisher Scientific have collaborated to advance blood-based infectious disease detection technology through the creation of highly sensitive liquid chromatography-mass spectrometry (LC-MS)-based workflows. NanoPin Technologies, Inc. is the creator of the novel NanoPin diagnostic platform for rapid and quantified results from patient blood samples.
Curious about this latest version of the report? @
https://www.insightaceanalytic.com/customisation/2056
Segmentation of Bacterial Diagnostics in Aquaculture Market-
By Animal Type-
• Mackerel
• Carps
• Milkfish
• Sea Bream
• Sea Bass
• Trout
• Crustaceans
• Other Species
By Technique
• Histopathology
• Electron microscopy
• Scanning Electron Microscopy
• Transmission Electron Microscopy
• Molecular Diagnostics
• Polymerase Chain Reaction (PCR)
• Real-Time PCR
• Multiple Loop-Mediated Isothermal Amplification PCR
• Quantitative PCR
• Arbitrary Primed PCR
• DNA Probes
• DNA Microarrays
• Immunological Diagnostics
• Immunohistochemistry (IHC)
• Immunofluorescent Antibody Test (IFAT)
• Immunochromatography
By Distribution Channel-
• Aquarium Store
• E-Commerce
• Company Stores
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get more information: @
https://www.insightaceanalytic.com/report/bacterial-diagnostics-in-aquaculture-market/2056
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bacterial Diagnostics in Aquaculture Market expected to Witness Huge Revenue Growth to 2031 here
News-ID: 3846772 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market to Grow at 5 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market- (By Product Type (Combined Nutritional Supplements, Single Nutritional Supplements), By Type Indication (Perimenopause, PMS), By Formulation (Capsules/Tablets, Powder, Softgels, Other), By Sales Channel (Pharmacies/Drug Stores, Online Sales Channel, Direct Sales Channel, Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research…
Cell and Gene Therapy CRO Market Forecast Shows Robust Growth Across North Ameri …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy CRO Market- (By Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), By Type of Genetic Modification (Ex vivo and In vivo), By Stage of Development (Discovery, Preclinical, and Clinical)), By Therapeutic Area, By End-user, By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by…
Bioseparation Systems Market Top Companies Study - GE Healthcare Life Sciences, …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bioseparation Systems Market- (By Type (Centrifugation Technology, Cell Disruption Technology, Chromatography Technique, Extraction Technique, Filtration Technologies and Membrane-based Bioseparation and Precipitation), Application (Food, Life Sciences, Pharmaceutical and Biopharmaceutical)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Bioseparation Systems Market is valued at US$…
Medical Nutrition Market Key Players Analysis - Abbott Laboratories; Pfizer Inc. …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Medical Nutrition Market Size, Share & Trends Analysis Report By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes), By Patient Type (Infants, Adults, And Geriatric Populations), Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes), End-User (Home Care Settings, Long-Term Care Facilities, And Ambulatory Surgical…
More Releases for Bacterial
Prominent Bacterial Conjunctivitis Market Trend for 2025: Innovative Eye Drops T …
What Are the Projected Growth and Market Size Trends for the Bacterial Conjunctivitis Market?
The bacterial conjunctivitis market has grown steadily, projected to expand from $4.52 billion in 2024 to $4.76 billion in 2025, at a CAGR of 5.3%. Growth factors include rising bacterial infection cases, improved diagnostics, patient education programs, stringent regulatory frameworks, and physician training.
The bacterial conjunctivitis market is projected to grow steadily, reaching $5.54 billion by 2029 at…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances can…
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
